Screening a panel of drugs with diverse mechanisms of action yields potential therapeutic agents against neuroblastoma
Jinesh Gheeya(National Cancer Institute), Javed Khan(Kent State University), Joon‐Yong Chung(National Institutes of Health), Jun S. Wei(Center for Cancer Research), Peter A. Johansson(AstraZeneca (Sweden)), Adam Cheuk(National Institutes of Health), Qingrong Chen(National Cancer Institute), Thomas Badgett, Christopher D. Benjamin(Vancouver General Hospital), Belhu Metaferia(National Cancer Institute), Patricia Tsang(National Institutes of Health), Stephen M. Hewitt(National Institutes of Health)
Cited by 27
Related Papers
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2018|6.3k
Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks
|Nature Medicine|2001|2.7k
The genetic landscape of high-risk neuroblastoma
|Nature Genetics|2013|1.2k